
Glenmark Pharmaceuticals’ USA arm reaches $37.75 million settlement in US antitrust lawsuit
Glenmark USA is named in multiple class actions and direct-action suits, brought by direct purchasers, end-payers, indirect purchasers, and private plaintiffs. The cases allege both…








